Fda Releases New Guidance On Psychedelic Drugs

Media Summary: ABC News News Chief Medical Correspondent Dr. Jen Ashton explains draft The Food and Drug Administration granted a quick review of three experimental A day after the DOJ said it would ease restrictions on medical marijuana, the

Fda Releases New Guidance On Psychedelic Drugs - Detailed Analysis & Overview

ABC News News Chief Medical Correspondent Dr. Jen Ashton explains draft The Food and Drug Administration granted a quick review of three experimental A day after the DOJ said it would ease restrictions on medical marijuana, the President Trump has signed an executive order to expand research into ... Reporter Anjalee Khemlani reports on the Rep. Dan Crenshaw, R-Texas, and Rep. Ro Khanna, D-Calif., filed a bill requiring the

With Sergio Pérez Rosas (moderator), Amy Emerson, Jamilah R. George, Sue Sisley and Joseph McCowan.

Photo Gallery

FDA releases new guidance on psychedelic drugs

FDA fast-tracks review of psychedelic drugs for mental health treatment

FDA fast-tracking its review of two psychedelic drugs for mental health treatments

FDA’s guidance on clinical trials with psychedelic drugs

FDA grants quick review for 3 psychedelic drug trials

FDA moves to fast-track three psychedelic drugs for review

FDA fast-tracks psychedelic drug reviews for mental health treatments

FDA to review three psychedelic drugs

FDA commissioner says decision on psychedelic treatments will be out 'quickly'

The FDA is fast tracking the review of some psychedelic-based medicines for mental health treatment

FDA prioritizes research into psychedelics for mental health treatment

Doctor talks about FDA fast tracking psychedelics

View Detailed Profile

FDA releases new guidance on psychedelic drugs

FDA releases new guidance on psychedelic drugs

The

FDA fast-tracks review of psychedelic drugs for mental health treatment

FDA fast-tracks review of psychedelic drugs for mental health treatment

The

FDA fast-tracking its review of two psychedelic drugs for mental health treatments

FDA fast-tracking its review of two psychedelic drugs for mental health treatments

The

FDA’s guidance on clinical trials with psychedelic drugs

FDA’s guidance on clinical trials with psychedelic drugs

ABC News News Chief Medical Correspondent Dr. Jen Ashton explains draft

FDA grants quick review for 3 psychedelic drug trials

FDA grants quick review for 3 psychedelic drug trials

The Food and Drug Administration granted a quick review of three experimental

FDA moves to fast-track three psychedelic drugs for review

FDA moves to fast-track three psychedelic drugs for review

A day after the DOJ said it would ease restrictions on medical marijuana, the

FDA fast-tracks psychedelic drug reviews for mental health treatments

FDA fast-tracks psychedelic drug reviews for mental health treatments

Drugs

FDA to review three psychedelic drugs

FDA to review three psychedelic drugs

The

FDA commissioner says decision on psychedelic treatments will be out 'quickly'

FDA commissioner says decision on psychedelic treatments will be out 'quickly'

FDA

The FDA is fast tracking the review of some psychedelic-based medicines for mental health treatment

The FDA is fast tracking the review of some psychedelic-based medicines for mental health treatment

The Food and

FDA prioritizes research into psychedelics for mental health treatment

FDA prioritizes research into psychedelics for mental health treatment

The U.S. Food and

Doctor talks about FDA fast tracking psychedelics

Doctor talks about FDA fast tracking psychedelics

Doctor talks about

FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics

FDA Commissioner Marty Makary breaks down Trump's executive order on psychedelics

President Trump has signed an executive order to expand research into

FDA issues draft guidance on psychedelic clinical trials for LSD, MDMA, mushrooms

FDA issues draft guidance on psychedelic clinical trials for LSD, MDMA, mushrooms

... Reporter Anjalee Khemlani reports on the

FDA Fast-Tracks Review of Psychedelic Drugs for Mental Health Treatment

FDA Fast-Tracks Review of Psychedelic Drugs for Mental Health Treatment

The U.S.

FDA fast-tracks psychedelic drug research for depression, PTSD treatment

FDA fast-tracks psychedelic drug research for depression, PTSD treatment

The

FDA issues guidance on clinical trials with psychedelic drugs | The Hill

FDA issues guidance on clinical trials with psychedelic drugs | The Hill

Rep. Dan Crenshaw, R-Texas, and Rep. Ro Khanna, D-Calif., filed a bill requiring the

Digesting the FDA Decision and the Future of Psychedelic Treatments | PCU25

Digesting the FDA Decision and the Future of Psychedelic Treatments | PCU25

With Sergio Pérez Rosas (moderator), Amy Emerson, Jamilah R. George, Sue Sisley and Joseph McCowan.

FDA chief Dr. Makary unpacks psychedelics research boosted by Trump executive order

FDA chief Dr. Makary unpacks psychedelics research boosted by Trump executive order

President Trump has signed an executive order to expand research into

FDA Is Fast-Tracking Three Psychedelic Drugs for Review

FDA Is Fast-Tracking Three Psychedelic Drugs for Review

The